January, 2022 | Press release
Patient Enrollment is Complete in the DOD-Funded Study of Extracorporeal Hemopurification of Critically Ill COVID-19 Patients

MARTINEZ, Calif. – PURIFY OBS, an observational study of critically-ill COVID patients treated with the Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100), has recently completed enrollment. Download the full article...

Read more
January, 2022 | Press release
Treatment for critically ill COVID patients results in significant improvement in survival rate according to new study

MARTINEZ, Calif. – Critically ill patients treated with ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) within 60 hours of ICU admission experienced a survival rate double that of patients treated...

Read more
December, 2021 | Press release
ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill

MARTINEZ, Calif. – ExThera Medical and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for ExThera’s Seraph®...

Read more
December, 2021 | Publication
How to save a life: Local firefighter with COVID-19 gets brand new treatment

How to save a life: Local firefighter with COVID-19 gets brand new treatment.   Download the full article here

Read more
October, 2021 | Publication
Absorption of Circulating Tumor Cells by Hemoperfusion

Absorption of Circulating Tumor Cells by Hemoperfusion Download the full article here

Read more
September, 2021 | Publication
Heart to Heart: Albany man beats COVID-19 thanks to promising treatment

Heart to Heart: Albany man beats COVID-19 thanks to promising treatment Download the full article here

Read more
September, 2021 | Publication
ExThera’s Device-Centered COVID-19 Treatment

ExThera Medical blood filter technology could play a crucial role in treating critically ill patients suffering from COVID-19. The Martinez, CA-based company is beginning a randomized clinical trial of the...

Read more
September, 2021 | Press release
Treatment for Critically Ill COVID Patients Begins 1st Randomized Clinical Trial. Study to Investigate ExThera Medical Seraph® 100 Microbind® Affinity Blood Filter’s. Ability to Reduce ICU Length of Stay and Mortality Rate

MARTINEZ, Calif. – Physicians across the country are using ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) under emergency use authorization from the U.S. Food and Drug Administration...

Read more
August, 2021 | Press release
Canadian Health Authority Grants ExThera’s Seraph 100 Blood Filter an Interim Order for Treatment of COVID-19

MARTINEZ, Calif. – As areas in Canada are seeing significant growth in Delta variant cases, surpassing that of the prior surge, ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter has...

Read more
July, 2021 | Press release
ExThera Expands Distribution of Blood Purification and Pathogen Reduction Treatment for Sepsis and COVID-19 in Europe. ExThera Medical and Fresenius Medical Care to offer Seraph 100 Microbind Affinity Filter in Turkey, Finland, and Estonia

MARTINEZ, Calif. – ExThera Medical, maker of the only effective pathogen-removal, hemoperfusion filter approved for patient use in Europe, and Fresenius Medical Care, the world’s leading provider of products and...

Read more